Application of emerging safety biomarkers in drug development

被引：0
|
作者：
Aubrecht, J. [1 ]
机构：
[1] Pfizer Inc, Drug Safety R&D, Groton, CT 06340 USA
来源：
TOXICOLOGY LETTERS | 2016年 / 259卷
关键词：
D O I：
10.1016/j.toxlet.2016.07.171
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
W4-2
引用
收藏
页码：S67 / S68
页数：3
相关论文
共 50 条
  • [1] Safety biomarkers in early drug development
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 146 - 146
  • [2] Emerging RNA editing biomarkers will foster drug development
    van der Laan, Siem
    Salvetat, Nicolas
    Weissmann, Dinah
    Molina, Franck
    DRUG DISCOVERY TODAY, 2017, 22 (07) : 1056 - 1063
  • [3] Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis
    Cavallaro, Sebastiano
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (31) : 3507 - 3507
  • [4] Emerging applications of kinetic biomarkers in preclinical and clinical drug development
    Turner, SM
    Hellerstein, MK
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (01) : 115 - 126
  • [5] Value of new biomarkers for safety testing in drug development
    Hewitt, Philip
    Herget, Thomas
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) : 531 - 536
  • [6] Safety biomarkers: Opportunities and challenges in drug discovery and development
    Schuppe-Koistinen, Ina
    TOXICOLOGY LETTERS, 2012, 211 : S9 - S9
  • [7] Safety differentiation: emerging competitive edge in drug development
    Uteng, Marianne
    Urbane, Laszlo
    Brees, Dominique
    Muller, Patrick Y.
    Kullak-Ublick, Gerd A.
    Bouchard, Page
    Tougas, Gervais
    Chibout, Salah-Dine
    DRUG DISCOVERY TODAY, 2019, 24 (01) : 285 - 292
  • [8] Monitoring kidney safety in drug development: Emerging technologies and their implications
    Dieterle, Frank
    Marrer, Estelle
    Suzuki, Eiko
    Grenet, Olivier
    Cordier, Andre
    Vonderscher, Jacky
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (01) : 60 - 71
  • [9] The development for emerging biomarkers of lymphangioleiomyomatosis
    Huang, Liting
    Xiao, Ying
    Yang, Lulu
    Ren, Siying
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [10] Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
    Liu, Han
    Ibrahim, Eman I. K.
    Centanni, Maddalena
    Sarr, Celine
    Venkatakrishnan, Karthik
    Friberg, Lena E.
    ADVANCED DRUG DELIVERY REVIEWS, 2025, 216
12345